Option chain shows key data for Satellos Bioscience's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Satellos Bioscience.

Satellos Bioscience (OTC:MSCLF) Stock, Option Chain

Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

SATELLOS BIOSCIENCE INC by SATELLOS BIOSCIENCE INC.

Satellos Bioscience Inc

Press Releases

Satellos Announces First Participant with Duchenne Muscular Dystrophy Dosed in the Phase 1b Clinical Trial of SAT-3247

Satellos to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Satellos Announces Completed Enrollment of all Four Multiple-Ascending Dose Cohorts for the Phase 1 Clinical Trial of SAT-3247 in Healthy Volunteers

Satellos Announces Upcoming Presentation at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Satellos Presents Initial Data from the Phase 1 Trial of SAT-3247 at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Satellos Reports 2024 Financial Results and Highlights Company Progress

Satellos to Participate in Two April Investor Conferences

Satellos to Present at Bloom Burton & Co. Healthcare Investor Conference

Satellos to Present at the CureDuchenne FUTURES National Conference

Satellos Reports First Quarter 2025 Results and Highlights Recent Company Progress

MSCLF

TSX:MSCL

Satellos Bioscience

Comments

Satellos Bioscience

Satellos Bioscience (MSCLF) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell